Corbus Pharmaceuticals Holdings Balance Sheet (2013-2026)

Reported Financials

Corbus Pharmaceuticals Holdings Quarterly Balance Sheet

Periods 53 quarters

Latest Sep 2026

Corbus Pharmaceuticals Holdings reported total assets of $122.90M and total liabilities of $38.14M for the quarter ended Sep 2026, up 12.2% year over year. This balance sheet covers 53 quarters of results from Sep 2013 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026	Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	25.01M	57.03M	25.77M	12.44M	17.00M	7.32M	8.35M	11.25M	13.72M	14.10M	23.69M	19.42M	17.20M	18.90M	20.04M	26.98M	28.49M	25.66M	23.37M	30.25M
Short-term InvestmentsInvestments (Current)	72.64M	29.09M	47.53M	53.79M	42.19M	36.90M	28.22M	17.48M	7.18M	106.00M	123.34M	139.94M	131.86M	113.89M	96.55M	77.00M	134.78M	112.56M	94.57M	85.09M
Cash & Current Investments	22.50M	86.12M	73.30M	2.81M	0.00M	1.99M	1.11M	1.35M	2.43M	120.10M	147.03M	159.36M	149.06M	132.79M	116.59M	103.98M	163.27M	138.22M	117.94M	115.34M
Receivables - NetNet Receivables
Receivables - OtherOther Receivables
Receivables
Current Deferred Tax AssetsCurrent Deferred Tax													-105.64M
Prepaid Assets	2.37M	2.16M	1.74M	0.93M	0.79M	1.45M	1.52M	2.28M	2.45M	1.31M	1.00M	1.24M	3.63M	4.29M	5.95M	3.30M	3.02M	4.96M	4.81M	3.61M
Current Assets	100.20M	88.48M	75.24M	67.35M	60.18M	45.86M	38.27M	31.21M	23.55M	121.70M	148.31M	160.89M	152.98M	137.36M	122.83M	107.57M	166.95M	143.57M	122.75M	118.95M
Non-Current Assets
Construction in Progress
Property, Plant & Equipment (Net)PP&E (Net)	2.39M	2.21M	1.99M	1.80M	1.61M	1.43M	1.27M	1.12M	0.97M	0.82M	0.67M	0.52M	0.39M	0.30M	0.25M	0.20M	0.16M	0.12M	0.07M	0.04M
Long-Term Investments					16.75M
Other Non-Current Assets	0.52M	0.55M	0.58M	0.61M	0.63M	0.66M	0.69M	0.68M	0.69M	0.38M	1.06M	1.06M	0.39M	0.39M	0.39M	0.39M	1.81M	2.08M	3.11M	2.59M
Non-Current Assets	7.53M	7.20M	6.83M	6.48M	6.13M	5.78M	5.45M	5.08M	4.73M	4.05M	3.67M	3.28M	2.90M	2.57M	2.26M	1.94M	1.24M	0.91M	4.24M	3.95M
Assets	107.73M	95.68M	82.07M	73.83M	66.31M	51.65M	43.72M	36.28M	28.27M	125.74M	151.98M	164.17M	155.88M	139.93M	125.09M	109.51M	168.20M	144.48M	126.99M	122.90M
Liabilities
Current Liabilities
Accounts Payables	1.78M	2.70M	1.99M	1.37M	2.17M	1.32M	1.51M	4.71M	3.18M	2.08M	1.15M	2.89M	4.79M	4.07M	3.99M	2.74M	2.22M	0.44M	5.25M	4.07M
Notes Payables	0.77M	0.44M	0.11M		0.35M	0.20M	0.05M		0.30M	0.19M	0.08M
Payables	2.55M	3.14M	2.10M	1.37M	2.53M	1.53M	1.56M	4.71M	3.48M	2.27M	1.23M	2.89M	4.79M	4.07M	3.99M	2.74M	2.22M	0.44M	5.25M	4.07M
Accumulated Expenses	10.09M	5.50M	4.72M	4.83M	6.00M	6.47M	6.42M	7.55M	11.03M	9.40M	10.49M	7.18M	5.43M	5.90M	7.65M	12.58M	16.84M	16.50M	15.23M	30.17M
Other Accumulated Expenses	1.74M	1.17M	1.21M	1.24M	1.28M	1.32M	1.36M	1.40M	1.44M	1.48M	1.52M	1.56M	1.61M	1.65M	1.70M	1.74M	1.63M
Short term Debt	3.09M	5.18M	7.47M	9.88M	2.80M	5.01M	7.02M	17.85M	15.91M	12.76M
Current Deferred Revenue
Total Current Liabilities	17.01M	15.12M	15.63M	17.47M	12.64M	14.36M	16.39M	31.54M	31.89M	25.92M	23.98M	11.63M	11.82M	11.62M	13.33M	17.06M	20.69M	18.14M	21.48M	34.97M
Non-Current Liabilities
Non-Current Debt	15.64M	13.73M	11.61M	9.39M	15.98M	13.97M	11.32M		15.91M		10.74M
Non-Current Deferred Revenue
Preferred Stock Liabilities
Operating Leases	5.96M	5.65M	5.33M	5.01M	4.68M	4.33M	3.98M	3.61M	3.24M	2.86M	2.46M	2.05M	1.63M	1.21M	0.76M	0.31M		1.21M	3.27M	3.18M
Other Non-Current Liabilities	0.02M	0.02M	0.02M	0.02M	0.02M	2.52M	0.02M	0.04M	0.04M
Total Non-Current Liabilities	38.60M	34.50M	32.57M	31.86M	33.30M	32.66M	34.18M	35.93M	35.13M	28.78M	26.44M	13.67M	13.45M
Total Liabilities	38.62M	34.52M	32.60M	31.88M	33.32M	35.19M	34.20M	35.97M	35.18M	28.78M	26.44M	13.67M	13.45M	12.83M	14.09M	17.37M	20.69M	18.14M	24.75M	38.14M
Shareholder's Equity
Total Debt	19.50M	19.35M	19.20M	19.27M	19.13M	19.18M	18.39M	17.85M	32.12M	12.95M	10.82M
Common Equity	69.11M	61.16M	49.47M	41.95M	32.99M	16.46M	9.52M	0.31M	-6.91M	96.97M	125.54M	150.50M	142.43M	127.11M	110.99M	92.15M	147.50M	126.34M	102.24M	84.76M
Liabilities and Shareholders Equity	107.73M	95.68M	82.07M	73.83M	66.31M	51.65M	43.72M	36.28M	28.27M	125.74M	151.98M	164.17M	155.88M	139.93M	125.09M	109.51M	168.20M	144.48M	126.99M	122.90M
Retained Earnings	-349.73M	-359.17M	-372.42M	-381.20M	-392.08M	-409.83M	-418.61M	-428.66M	-436.68M	-443.58M	-453.60M	-467.40M	-476.89M	-493.90M	-511.53M	-534.90M	-555.43M	-578.40M	-613.44M	-651.20M

Corbus Pharmaceuticals Holdings Balance Sheet API

Pull Corbus Pharmaceuticals Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CRBP&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "CRBP", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=CRBP&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Corbus Pharmaceuticals Holdings CRBP Balance Sheet (2013-2026)

Corbus Pharmaceuticals Holdings Quarterly Balance Sheet

Corbus Pharmaceuticals Holdings Balance Sheet API

Create an account

Sign In

Reset Password